Patent details

EP2211885 Title: COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES

Basic Information

Publication number:
EP2211885
PCT Application Number:
PCT/US/2008/079224
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088374517
PCT Publication Number:
WO/2009/048967
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES
French Title of Invention:
THÉRAPIE COMBINÉE ASSOCIANT DES CONJUGUÉS ANTICORPS-MÉDICAMENTS
German Title of Invention:
KOMBINATIONSTHERAPIE MIT ANTIKÖRPER-ARZNEIMITTEL-KONJUGATEN
SPC Number:

Dates

Filing date:
08/10/2008
Grant date:
29/07/2015
EP Publication Date:
29/07/2015
PCT Publication Date:
16/04/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2010
EP B1 Publication Date:
29/07/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/10/2015
Expiration date:
08/10/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/10/2008
 
 

Name:
Seattle Genetics Inc.
Address:
21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

Inventor

1

Name:
GERBER Hans-Peter
Address:
United States (US)

2

Name:
OFLAZOGLU Ezogelin
Address:
United States (US)

3

Name:
SIEVERS Eric
Address:
United States (US)

Priority

1

Priority Number:
979594 P
Priority Date:
12/10/2007
Priority Country:
United States (US)

2

Priority Number:
27668 P
Priority Date:
11/02/2008
Priority Country:
United States (US)

3

Priority Number:
40641 P
Priority Date:
28/03/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages